Author:
Paulo Lopes,Georg Dutschke,Cláudia Pereira,Elsa Belo,Diogo Morais,Paulo Caldeira,Filipa Barata,Emília Leitão,R Tato Marinho,Paula Peixe,José Vera,Rodrigo Coutinho
Abstract
The World Drug Report highlights that the prevalence of hepatitis C virus (HCV) is one of the leading causes of cirrhosis and hepatocellular carcinoma globally. This report estimates that HCV is responsible for the annual death of around 700,000 people due to liver disease and is associated with high levels of morbidity and mortality with high health and socio-economic costs. This exploratory study aims to evaluate the socio-economic return provided by HCV treatment of individuals integrated into the MOP developed by the NGO Ares do Pinhal in Portugal. Using the SROI (Social Return on Investment) methodology is estimated that for every euro invested in this program, the return for society is 3,75€. This is a significantly positive SROI value, highlighting the importance of this investment in the creation of monetized value for society, as well as to provide greater well-being to those who need it and to society as a whole.
Publisher
Heighten Science Publications Corporation
Reference29 articles.
1. 1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European drug report 2016: trends and developments. Luxembourg: Publications Office of the European Union; 2016. Available from: https://www.euda.europa.eu/publications/edr/trends-developments/2016_en
2. 2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European drug report 2019: trends and developments. Available from: https://www.emcdda.europa.eu/system/files/publications/11364/20191724_TDAT19001ENN_PDF.pdf
3. 3. Peterson C, Li M, Xu L, Mikosz CA, Luo F. Assessment of annual cost of substance use disorder in US hospitals. JAMA Netw Open. 2021;4(3): e210242. Available from: https://doi.org/10.1001%2Fjamanetworkopen.2021.0242
4. 4. Bouzanis K, Joshi S, Lokker C, Pavalagantharajah S, Qiu Y, Sidhu H, Alvarez E. Health programs and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review. BMJ Open. 2021;11(9):e047511. Available from: https://doi.org/10.1136/bmjopen-2020-047511
5. 5. World Health Organization (WHO). Guidelines for the screening, care, and treatment of persons with chronic hepatitis C infection. Update version; 2016. Available from:: https://www.ncbi.nlm.nih.gov/books/NBK362924/.